NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $251,055 | -1.6% | 20,411 | +28.5% | 0.00% | 0.0% |
Q2 2023 | $255,176 | +77.8% | 15,879 | +2.3% | 0.00% | – |
Q4 2022 | $143,488 | -54.6% | 15,529 | -57.7% | 0.00% | -100.0% |
Q3 2022 | $316,000 | +102.6% | 36,676 | +91.6% | 0.00% | – |
Q2 2022 | $156,000 | +6.1% | 19,140 | +58.2% | 0.00% | – |
Q1 2022 | $147,000 | -68.5% | 12,098 | -11.4% | 0.00% | -100.0% |
Q4 2021 | $466,000 | -36.3% | 13,660 | -10.0% | 0.00% | 0.0% |
Q3 2021 | $732,000 | +6.7% | 15,177 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $686,000 | -6.3% | 15,177 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $732,000 | -68.0% | 15,177 | -64.2% | 0.00% | -75.0% |
Q4 2020 | $2,286,000 | -17.2% | 42,451 | -43.3% | 0.00% | -20.0% |
Q3 2020 | $2,761,000 | -17.8% | 74,846 | -31.0% | 0.01% | 0.0% |
Q2 2020 | $3,359,000 | -13.5% | 108,440 | -22.9% | 0.01% | -28.6% |
Q1 2020 | $3,882,000 | +40.7% | 140,591 | +49.1% | 0.01% | +133.3% |
Q4 2019 | $2,759,000 | -10.5% | 94,321 | -41.5% | 0.00% | -25.0% |
Q3 2019 | $3,084,000 | -37.5% | 161,292 | -28.2% | 0.00% | -33.3% |
Q2 2019 | $4,932,000 | +56.6% | 224,779 | +46.0% | 0.01% | +100.0% |
Q1 2019 | $3,150,000 | +54.1% | 153,950 | -5.0% | 0.00% | +50.0% |
Q4 2018 | $2,044,000 | +382.1% | 162,059 | +486.3% | 0.00% | – |
Q3 2018 | $424,000 | +155.4% | 27,641 | +117.8% | 0.00% | – |
Q2 2018 | $166,000 | -6.7% | 12,692 | -42.0% | 0.00% | – |
Q1 2018 | $178,000 | -8.2% | 21,864 | 0.0% | 0.00% | – |
Q4 2017 | $194,000 | -20.2% | 21,864 | 0.0% | 0.00% | – |
Q3 2017 | $243,000 | -6.2% | 21,864 | -24.5% | 0.00% | – |
Q2 2017 | $259,000 | +13.1% | 28,952 | -0.4% | 0.00% | – |
Q1 2017 | $229,000 | -36.2% | 29,081 | -30.5% | 0.00% | – |
Q4 2016 | $359,000 | +4.1% | 41,860 | -0.3% | 0.00% | -100.0% |
Q3 2016 | $345,000 | +24.5% | 42,001 | +22.0% | 0.00% | – |
Q2 2016 | $277,000 | +19.4% | 34,426 | 0.0% | 0.00% | – |
Q1 2016 | $232,000 | -12.1% | 34,426 | +2.8% | 0.00% | – |
Q4 2015 | $264,000 | -15.1% | 33,485 | -38.3% | 0.00% | -100.0% |
Q3 2015 | $311,000 | +23.4% | 54,270 | +16.6% | 0.00% | – |
Q2 2015 | $252,000 | +58.5% | 46,541 | +36.9% | 0.00% | – |
Q1 2015 | $159,000 | +63.9% | 34,000 | +45.9% | 0.00% | – |
Q4 2014 | $97,000 | +83.0% | 23,300 | +128.4% | 0.00% | – |
Q3 2014 | $53,000 | – | 10,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |